Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Chemosphere ; 303(Pt 1): 134861, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35584713

ABSTRACT

The use of tetracycline hydrochloride (TCH) for veterinary, human therapy, and agriculture has risen in the past few decades, making it to become one of the most exploited antibiotics. However, TCH residue in the environment is causing issues related to the evolution of antibiotic-resistant bacteria. To address such a problem, photodegradation offers a potential solution to decompose these pollutants in wastewater and thereby mitigates negative environmental impacts. In this context, the research focuses on the use of the rare-earth metal oxide samarium orthovanadate (SmVO4) with nanorod structure, coupled with UiO-66-NH2 for the photocatalytic degradation. Their photocatalytic activity to degrade antibiotic TCH molecules is explored under simulated solar light irradiation. The integration of UiO-66-NH2 with SmVO4 enhanced the light absorption, recombination resistance, carrier lifetime (from 0.382 to 0.411 ns) and specific surface area (from 67.17 to 246 m2/g) of the composite system as confirmed from multiple analyses. The obtained results further indicated that SmVO4/UiO-66-NH2 nanocomposites could form a direct Z-scheme based heterojunction. Such mechanism of charge transfer leads to the effective degradation of TCH molecules up to 50% in 90 min under solar light, while it is degraded only 30% in the case of bare-SmVO4 nanorods. In this work, the incorporation of UiO-66-NH2 positively influences photoelectrochemical properties and improves the overall photoredox properties of SmVO4 for the degradation of complex compounds like antibiotic TCH molecules. Therefore, UiO-66-NH2 can be proposed as an effective material to sensitize the rare-earth based photocatalytic material.


Subject(s)
Nanocomposites , Tetracycline , Anti-Bacterial Agents , Catalysis , Humans , Metal-Organic Frameworks , Nanocomposites/chemistry , Phthalic Acids , Sunlight
2.
PLoS One ; 12(5): e0176650, 2017.
Article in English | MEDLINE | ID: mdl-28459862

ABSTRACT

Chronic kidney disease is associated with homeostatic imbalances such as insulin resistance. However, the underlying mechanisms leading to these imbalances and whether they promote the development of type 2 diabetes is unknown. The effect of chronic kidney disease on insulin resistance was studied on two different rat strains. First, in a 5/6th nephrectomised Sprague-Dawley rat model of chronic kidney disease, we observed a correlation between the severity of chronic kidney disease and hyperglycemia as evaluated by serum fructosamine levels (p<0.0001). Further, glucose tolerance tests indicated an increase of 25% in glycemia in chronic kidney disease rats (p<0.0001) as compared to controls whereas insulin levels remained unchanged. We also observed modulation of glucose transporters expression in several tissues such as the liver (decrease of ≈40%, p≤0.01) and muscles (decrease of ≈29%, p≤0.05). Despite a significant reduction of ≈37% in insulin-dependent glucose uptake in the muscles of chronic kidney disease rats (p<0.0001), the development of type 2 diabetes was never observed. Second, in a rat model of metabolic syndrome (Zucker Leprfa/fa), chronic kidney disease caused a 50% increased fasting hyperglycemia (p<0.0001) and an exacerbated glycemic response (p<0.0001) during glucose challenge. Similar modulations of glucose transporters expression and glucose uptake were observed in the two models. However, 30% (p<0.05) of chronic kidney disease Zucker rats developed characteristics of type 2 diabetes. Thus, our results suggest that downregulation of GLUT4 in skeletal muscle may be associated with insulin resistance in chronic kidney disease and could lead to type 2 diabetes in predisposed animals.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/metabolism , Insulin Resistance/physiology , Renal Insufficiency, Chronic/metabolism , Animals , Disease Progression , Glucose/metabolism , Glucose Transporter Type 4/metabolism , Glycosuria/metabolism , Liver/metabolism , Male , Muscle, Skeletal/metabolism , Nephrectomy , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Rats, Zucker , Risk , Sodium-Glucose Transport Proteins/metabolism , Tissue Culture Techniques
3.
J Chem Phys ; 127(17): 174107, 2007 Nov 07.
Article in English | MEDLINE | ID: mdl-17994807

ABSTRACT

A time-dependent multiconfiguration self-consistent field (TDMCSCF) scheme is developed to describe the time-resolved electron dynamics of a laser-driven many-electron atomic or molecular system, starting directly from the time-dependent Schrodinger equation for the system. This nonvariational formulation aims at the full exploitations of concepts, tools, and facilities of existing, well-developed quantum chemical MCSCF codes. The theory uses, in particular, a unitary representation of time-dependent configuration mixings and orbital transformations. Within a short-time, or adiabatic approximation, the TDMCSCF scheme amounts to a second-order split-operator algorithm involving generically the two noncommuting one-electron and two-electron parts of the time-dependent electronic Hamiltonian. We implement the scheme to calculate the laser-induced dynamics of the two-electron H2 molecule described within a minimal basis, and show how electron correlation is affected by the interaction of the molecule with a strong laser field.

SELECTION OF CITATIONS
SEARCH DETAIL